O
n a first-quarter earnings call Thursday, Emergent’s CEO addressed a turbulent month for the Gaithersburg biopharmaceutical company.
Image: https://www.bizjournals.com
{iframe}https://www.bizjournals.com/washington/news/2021/04/29/emergent-biosolutions-to-submit-response-to-fda.html{/iframe}